Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement or therapeutic product containing both fish oil omega-3 fatty acids (primarily eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and olive oil. Fish oil omega-3 fatty acids are polyunsaturated fats that play critical roles in metabolism, cellular function, and cardiovascular health. They are well-established for reducing triglyceride levels in the blood, with prescription forms approved for severe hypertriglyceridemia and as adjuncts to secondary prevention after myocardial infarction[1][2][5]. Olive oil is a plant-derived monounsaturated fat known for its anti-inflammatory properties and cardiovascular benefits. Clinical studies suggest that combining fish oil omega-3 fatty acids with olive oil may provide enhanced improvements in inflammatory conditions such as rheumatoid arthritis compared to fish oil alone[6]. The mechanism of action involves modulation of lipid metabolism, reduction of inflammation through effects on eicosanoid synthesis, inhibition of platelet aggregation, and improvement in endothelial function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fish oil omega-3 fatty acids + olive oil.